Refined technologies have led to improved detection of abnormalities in the anatomical structures and function of the heart. Defects found are either congenital or due to gradual deterioration from disease. High blood pressure, medications, aging, plaque in coronary arteries, rheumatic fever, and infection are but a few conditions that can result in structural heart disease. Addressing these disease states requires delicate procedures with premium catheter components and advanced biomaterials. Clinicians and engineers likewise require a partner who values precision as well as quality \u2013 that is where Zeus delivers.<\/p>\n
While advances are currently in development for many valve replacements, the most prevalent thus far are transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR). These procedures are\u00a0minimally invasive techniques to replace\u00a0these critical\u00a0heart valves and restore as close to normal heart function as possible. This emerging catheter-based technology accesses the heart through either the femoral artery (transfemoral) or the apex of the heart (transapical).<\/p>\n
Zeus products play a leading role in lifesaving TAVR and TMVR procedures. Our products are also highly featured in other procedures, including left atrial\u00a0appendage closure (LAAC) and the closure of atrial septal defects (ASD) and ventricular septal defects (VSD).\u00a0Delivery systems for these procedures use a range of Zeus products, including PTFE and Aeos\u2122 ePTFE liners,\u00a0FEP heat shrink, and pusher tubes made from nylon, PEEK, or polyethylene. Additionally, Aeos\u2122 ePTFE high strength suture monofilament can be used to repair or replace stretched, damaged, or broken\u00a0chordae tendineae<\/em>\u00a0to restore mitral valve function.<\/p>\n